GENEVA, July 6 -- ZEVRA THERAPEUTICS, INC. filed a patent application (US2025/061053) for “PRODRUGS OF ARIMOCLOMOL FOR TREATING NEURODEGENERATIVE METABOLIC DISEASES”. With publication no. WO/2026/143069, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 401/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....